Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Lowered to $143 at Needham & Company

February 7, 2022 1:42 PM
Needham & Company analyst Mike Matson lowered the price target on Zimmer Biomet (NYSE: ZBH) to $143.00 (from $155.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles